Autonomix Medical, Inc.AMIX
ASignal's systematic analysis rates AMIX as Bearish.
Reflects the latest available analysis · analyzed Aug 27, 2026
The case on AMIX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $3.46M in cash and no debt
- High current and quick ratios indicating strong short-term liquidity
- RSI at 19.94 suggesting deeply oversold conditions
- Negative return on equity (-315.99%) and return on assets (-157.81%)
- Negative operating cash flow ($-13.22M) and free cash flow ($-7.62M)
- Negative forward P/E and EV/EBITDA suggesting unprofitability
- Zero gross, operating, and net margins
- MACD below signal line with negative histogram indicating downtrend
- Price trading below SMA20 and SMA50, indicating bearish momentum
See the full verdict on AMIX
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes AMIX
Most investors never get a second opinion, let alone several. ASignal runs AMIX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.